S, M, L, XL . . .

Gut

Volumn 52, Issue 1, 2003, Pages 5-7

  Wang, T ^a   Triadafilopoulos, G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CONFOCAL MICROSCOPY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FLUORESCENCE; HUMAN; INTERMETHOD COMPARISON; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMICS; PRIORITY JOURNAL; SCREENING; ULTRASOUND;

BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 0037214356     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.1.5     Document Type: Note

References (21)

1. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
2. Reid BJ, Blount PL, Feng Z, et al. Optimizing endoscopic biopsy detection of early cancers in patients with high-grade dysplasia. Am J Gastroenterol 2000;95:3089-96.
3. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000;49:170-6.
4. Stevens PD, Lightdale CJ, Green PHR, et al. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994;40:747-9.
5. Guelrud M, Herrera I, Essenfeld H, et al. Enhanced magnification endoscopy: A new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559-65.
6. Endo T, Awakawa T, Takahashi H, et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 2002;55:641-7.
7. Sharma P, Weston AP, Topalovski M, et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gut 2003;52:24-7.
8. Egger K, Werner M, Meining A, et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2002;52:18-23.
9. Mayinger B, Neidhardt S, Reh H, et al. Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest Endosc 2001;54:572-8.
10. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.
11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
12. Scotiniotis IA, Kochman ML, Lewis JD, et al. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastroint Endosc 2001;54:689-96.
13. Dickensheets DL, Kino GS. A micramachined scanning confocal optical microscope. Optics Lett 1996;21:764-6.
14. Wong RK, Horwhat JD, Maydonovitch CL. Sky blue or murky waters: The diagnostic utility of methylene blue. Gastrointest Endosc 2001;54:409-13.
15. Canto MI, Setrakian S, Petras RE, et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 1996;44:1-7.
16. Canto MI, Setrakian S, Willis J, et al. Methylene blue staining of dysplastic and non-dysplastic Barrett's esophagus: An in vivo and ex vivo study. Endoscopy 2001;33:391-400.
17. Wo JM, Ray MB, Mayfield-Stokes S, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: A preliminary study. Gastrointest Endosc 2001;54:294-301.
18. Wang TD, Crawford JM, Feld MS, et al. In vivo identification of colonic dysplasia using fluorescence endoscopic imaging. Gastrointest Endosc 1999;49:447-55.
19. Haringsma J, Tytgat GNJ, Yano H, et al. Autofluorescence endoscopy: Feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 2001;53:642-50.
20. Bugaj JE, Achilefu S, Dorshow RB, et al. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. J Biomed Opt 2001;6:122-33.
21. Poneros JM, Brand S, Bouma BE, et al. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 2001;120:7-12.